The siRNA/Ap-CS efficiently knocks down the expression of Plk1 mRNA and PLK1 protein and exhibits the higher ability to induce the apoptosis of tumor cells than commercial transfection reagent lipofectamine 3000. The gene discussed is PLK1; the disease is neoplasm.